Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

12-month efficacy and safety of OROS MPH in children and adolescents with attention-deficit/hyperactivity disorder switched from MPH.

Hoare P, Remschmidt H, Medori R, Ettrich C, Rothenberger A, Santosh P, Schmit M, Spender Q, Tamhne R, Thompson M, Tinline C, Trott GE.

Eur Child Adolesc Psychiatry. 2005 Sep;14(6):305-9.

PMID:
16220214
2.

Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS MPH Results of a 3-week open-label study.

Remschmidt H, Hoare P, Ettrich C, Rothenberger A, Santosh P, Schmidt M, Spender Q, Tamhne R, Thompson M, Tinline C, Trott GE, Medori R.

Eur Child Adolesc Psychiatry. 2005 Sep;14(6):297-304.

PMID:
16220213
5.

Contracting for child health services in the community.

Polnay L, Bingham H, Tamhne R.

Arch Dis Child. 1993 Apr;68(4):517-20. No abstract available.

6.

Preschool vision screening.

Jarvis SN, Tamhne RC, Thompson L, Francis PM, Anderson J, Colver AF.

Arch Dis Child. 1991 Mar;66(3):288-94.

7.

Auditing community screening for undescended testes.

Tamhne RC, Jarvis SN, Waterston AJ.

Arch Dis Child. 1990 Aug;65(8):888-90.

8.

Laparoscopic diagnosis of ascites.

Tamhne RC.

Br Med J (Clin Res Ed). 1985 Sep 21;291(6498):825. No abstract available.

Supplemental Content

Loading ...
Support Center